Litigation
Where Should Investors Buy Facebook, Tesla and Netflix?
One of the three stocks looks OK to ease into now, but the technical signals indicate it would be best to wait on the other two.
TikTok Reprieve, Muddled Market, Awaiting the Great Debate: Market Recon
Plus, House Speaker Nancy Pelosi and Treasury Secretary Stephen Mnuchin agree to talk stimulus turkey.
Are Harvest Health's Legal Problems a Red Flag?
While HRVSF has navigated through numerous changes and delivered solid revenue, litigation issues are piling up.
China's Kingold Jewelry Allegedly Used Fake Gold to Secure Huge Loans
Lenders to the Nasdaq-listed jewelry maker reportedly have discoverd that 83 tons of gold used to borrow billions appear to be copper alloy bars.
Chinese Insurer Sues Korean Firm Over Failed Deal for 15 U.S. Luxury Hotels
The global nature of the Covid-19 crisis is clear in a filing in Delaware chancery court, as financing for flashy real estate deals has dried up.
Time to Buy a Reduced Price Ticket for Live Nation?
My strategy for shares of the concert promoter is simple.
Under Armour Loses Traction and Puts Chart Support Into Question
Shares of the shoe and apparel maker are reacting to reduced revenue guidance and word of government investigations into its accounting practices.
Is the Worst Over for Johnson & Johnson?
A lot of investing is just waiting until the market hates good companies.
A Sagging Drugmaker and Lagging Pet Health Name Both Worth Looks
Alexion Pharmaceuticals and Elanco Animal Health have seen their shares go to the dogs of late, but still offer reasons for portfolio consideration.
These Drug Cos. Could Soon Feel Big Side Effects of Opioid Crisis
No company is safe from the litigation risk tied to the drug epidemic, but Johnson & Johnson may be one of the few guaranteed to survive.